AIKO Biotechnology Overview

  • Founded
  • 2007
Founded
  • Status
  • Out of Business
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Out of Business

AIKO Biotechnology General Information

Description

Developer of drugs intended to be used for pain management and opioid addiction. The company's drugs focus on the discovery and validation of therapeutic compounds for the treatment of pain and the side effects associated with prescription opioid pain reliever use, such as opioid-induced bowel dysfunction, addiction and abuse, enabling patients to get a safer and more effective treatment for opioid-induced bowel dysfunction, addiction and overdose.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
  • 2 Union Street
  • Suite 501
  • Portland, ME 04101
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AIKO Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Nov-2016 00.00 Completed Out of Business
4. Early Stage VC (Series A) 01-Dec-2009 00.00 00.00 Completed Generating Revenue
3. Grant 20-Aug-2008 00000 000 Completed Generating Revenue
2. Grant 15-Sep-2007 $1M Completed Generating Revenue
1. Seed Round 25-Apr-2007 $1M $1M Completed Generating Revenue
To view AIKO Biotechnology’s complete valuation and funding history, request access »

AIKO Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs intended to be used for pain management and opioid addiction. The company's drugs focus on the discov
Drug Discovery
Portland, ME
2 As of 2015
00.00
00000000 00 00.00

000000

sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
000000000000000
Bridgewater, NJ
000 As of 0000
00000
000000000 00000

00000000

onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
0000 000000000
San Mateo, CA
00 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AIKO Biotechnology Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Insmed Formerly VC-backed Bridgewater, NJ 000 00000 000000000 00000
00000000 000000000 Formerly VC-backed San Mateo, CA 00 00000 000000&0 00000
0000000 Formerly VC-backed Emeryville, CA 000 00000 000000 - 000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 00000 000000&0 00000
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 00 00000 0000000000 0 00000
You’re viewing 5 of 9 competitors. Get the full list »

AIKO Biotechnology Executive Team (5)

Name Title Board Seat Contact Info
Wolfgang Sadee Co-Founder, Chief Scientific Officer & Board Member
Brian Dallaire Clinical Director
You’re viewing 2 of 5 executive team members. Get the full list »

AIKO Biotechnology Board Members (4)

Name Representing Role Since
Paul Goldenheim MD Self Board Member 000 0000
Wolfgang Sadee AIKO Biotechnology Co-Founder, Chief Scientific Officer & Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

AIKO Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial